A new matrix metalloproteinase-9 inhibitor 3,4-dihydroxycinnamic acid (caffeic acid) from methanol extract of Euonymus alatus: isolation and structure determination
- 28 February 2005
- journal article
- Published by Elsevier BV in Toxicology
- Vol. 207 (3), 383-390
- https://doi.org/10.1016/j.tox.2004.10.008
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Hepatitis B viral HBx induces matrix metalloproteinase‐9 gene expression through activation of ERKs and PI‐3K/AKT pathways: Involvement of invasive potentialThe FASEB Journal, 2004
- Isolation and Characterization of Some Antioxidative Compounds from the Rhizomes of Smaller Galanga (Alpinia officinarum Hance)Journal of Agricultural and Food Chemistry, 2003
- Inhibitory effect of methanol extract of Euonymus alatus on matrix metalloproteinase-9Journal of Ethnopharmacology, 2003
- Enhanced expression of matrix metalloproteinase-9 by hepatitis B virus infection in liver cellsArchives of Biochemistry and Biophysics, 2002
- Matrix metalloproteinase inhibition by green tea catechinsBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Matrix metalloproteinases as stromal effectors of human carcinoma progression: Therapeutic implicationsMatrix Biology, 1997
- Cytotoxic Cardenolides from Woods of Euonymus alata.CHEMICAL & PHARMACEUTICAL BULLETIN, 1996
- Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasisCancer and Metastasis Reviews, 1995
- Inhibitors of human immunodeficiency virus integrase.Proceedings of the National Academy of Sciences of the United States of America, 1993
- Caffeic acid is a selective inhibitor for leukotriene biosynthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984